Stocktoria
Arcosa, Inc. ACA
Arcosa, Inc. (ACA) earns a Piotroski F-score of 7/9 (strong financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 0.14% (safety: safe). FY2025 revenue was $2.9B at a 7.2% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.48 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-05-04 | Barclays | Overweight (main) |
| 2026-03-02 | DA Davidson | Buy (main) |
| 2025-11-03 | Barclays | Overweight (main) |
| 2025-08-11 | DA Davidson | Buy (main) |
| 2025-01-14 | Oppenheimer | Outperform (main) |
| 2024-10-29 | Barclays | Overweight (init) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 7/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.121 |
| Retained earnings / assets | 0.19 |
| EBIT / assets | 0.069 |
| Equity / liabilities | 1.127 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| ACA | Arcosa, Inc. | 7/9 | 3.06 | 34 | +12.2% |
| VMI | VALMONT INDUSTRIES INC | 5/9 | 6.8 | 30.8 | +0.7% |
| VATE | INNOVATE Corp. | 3/9 | -6.04 | — | +12.5% |
| PRLB | Proto Labs Inc | 6/9 | 10.59 | 90.4 | +6.4% |
| TPCS | TECHPRECISION CORP | 5/9 | -1.18 | — | -7% |
| VFS | VinFast Auto Ltd. | 4/9 | -13.01 | — | +57.9% |
| TM | TOYOTA MOTOR CORP/ | 7/9 | 2.55 | — | -1% |
About Arcosa, Inc.
Arcosa, Inc., together with its subsidiaries, provides infrastructure-related products and solutions for the construction, engineered structures, and transportation markets in the United States. The company operates through three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment offers natural and recycled aggregates; specialty materials; and construction site support equipment, including trench shields and shoring products for residential and non-residential construction, and specialty and other products, as well as for infrastructure construction. The Engineered Structures segment offers utility structures, wind towers, traffic and lighting structures, and telecommunication structures for electricity transmission and distribution, wind power generation, highway road construction, and wireless communication markets. This segment also sells its products to contractors and distributors serving state Departments of Transportation and state and municipality agencies. The Transportation Products segment offers inland barges, fiberglass barge covers, winches, marine hardware, and other transportation and industrial equipment to the commercial marine transportation companies, lessors, and industrial shippers. Arcosa, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
FAQ
Is ACA financially healthy?
Arcosa, Inc.'s Piotroski F-score is 7/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does ACA pay a dividend, and is it safe?
Yes. Arcosa, Inc. pays a dividend yielding about 0.14% with a 4.8% payout ratio, rated “safe” for safety.
How profitable is ACA?
In FY2025, Arcosa, Inc. had a net margin of 7.2% and a return on equity of 7.9%.
Is ACA overvalued or undervalued?
Arcosa, Inc. trades at about 34.2× trailing earnings — above its 10-year norm (10-year range 11.7×–53.0×, median 25.6×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for ACA?
The average Wall-Street price target for Arcosa, Inc. is $145.50, about 0.3% above the recent price, from 4 analysts (consensus: buy).
Is ACA a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Arcosa, Inc.: a Piotroski F-score of 7/9, an Altman Z″ in the safe zone, a P/E of about 34.0×, a dividend yield of 0.14%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.